Floatz logo

Varinon

Post-Operative Wound Seroma, Non-Human Animal

Ittefaq Hospital trustSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Post-Operative Wound Seroma, Non-Human Animal cohort.

Asset / SponsorPhaseRating
Artiss
Zuyderland Medisch Centrum
Phase 4BB
Tranexamic Acid
St. Olavs Hospital
Phase 4BB
4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)-
Ittefaq Hospital trust
Phase 4BB
L-CYSTEINAMIDE, D-PHENYLALANYL-L-CYSTEINYL-L-PHENYLALANYL-D-TRYPTOPHYL-L-LYSYL-L-THREONYL-N-(2-HYDROXY-1-(HYDROXYMETHYL)PROPYL)-, CYCLIC (2->7)-DISULFIDE, (R-(R*,R*))-
Chemi S.p.A.
Phase 2B

Same molecule, other indications

Varinon is also rated in:

chronic venous insufficiencyDormant
BB
Indicative · Phase 3
64 / 100
View asset →
pelvic congestion syndromeActive
B
Indicative · Phase 3
60 / 100
View asset →
metabolic dysfunction-associated steatohepatitisActive
B
Indicative · Phase 3
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →